BioSpace News Archive

Precision Spine, Inc., a medical device company dedicated to Made-in-the-USA manufacturing, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Dakota ACDF™ Standalone System in the treatment of degenerative disc disease (DDD).

Mrs. Birgans’ significant depth of experience spans wide across the media and entertainment sectors; from creating content and overseeing major media productions for companies including Game Show Network, Studio USA, MTV/Viacom, Animal Planet and Billboard Music; to producing live events for brands such as Honda, Lexus and Amgen.

Announced Richie Cunningham as new Chief Executive Officer Presented data from TYME-88-Panc Study at the American Society of Clinical Oncology 2021 Gastrointestinal Cancers Symposium Continued enrolling patients in multicenter randomized controlled TYME-88-Panc pivotal trial evaluating oral SM-88 as a potential treatment for third-line pancreatic cancer; full enrollment not expected before calendar year 2022

Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, announced its participation in the following 2021 virtual investor conferences.

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday,

TRANQUILITY to Utilize Two-Day Treatment and Challenge Design Consistent with Previously Announced Top-Line TRANQUILITY Run-In Cohort Results, Ocular Redness Selected as Primary Endpoint Tear RASP Levels Reduced After Single Doses of Reproxalap in Run-In Cohort of TRANQUILITY and Selected as Secondary Endpoint for Confirmation of Mechanism of Action

-Bioventus Inc. (“Bioventus” or the “Company”), today announced that it has commenced the initial public offering of its Class A common stock. Bioventus is offering 7,350,000 shares of its Class A common stock. The initial public offering price is expected to be between $16.00 and $18.00 per share. Bioventus expects to grant the underwriters a 30-day option to purchase up to an additional 1,102,500 shares of its common stock

Secarna Pharmaceuticals GmbH & Co. KG a biopharmaceutical company focusing on the discovery and development of next generation antisense oligonucleotide (ASO) therapies to address challenging or previously undruggable targets via its LNAplus TM platform, announced today that the Company has appointed Alexander Gebauer, MD, PhD as CEO and Managing Director.

Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of an offer to purchase for cash (the “Cash Offer”) any and all of its outstanding 5.200% Senior Notes due 2045 (the “Notes”), totaling $1.75 billion in aggregate principal amount, on the terms and conditions set forth in the Offer to Purchase dated February 4, 2021

Insightec, a global healthcare company focused on creating the next generation of patient care, today announced that it has received FDA IDE approval to conduct a pivotal study to evaluate staged, bilateral Focused Ultrasound treatment of patients with medication-refractory Essential Tremor.